Exact Sciences
EXAS
#1709
Rank
ยฃ7.92 B
Marketcap
ยฃ42.81
Share price
0.96%
Change (1 day)
-17.56%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ2.82 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are ยฃ2.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ2.61 B-0.79%
2022-12-31ยฃ2.63 B7.73%
2021-12-31ยฃ2.44 B23.8%
2020-12-31ยฃ1.97 B112.48%
2019-12-31ยฃ0.92 B39.82%
2018-12-31ยฃ0.66 B1048.73%
2017-12-31ยฃ57.81 M70.9%
2016-12-31ยฃ33.83 M34.87%
2015-12-31ยฃ25.08 M63.82%
2014-12-31ยฃ15.31 M123.31%
2013-12-31ยฃ6.85 M-18.05%
2012-12-31ยฃ8.36 M-3.36%
2011-12-31ยฃ8.65 M-20.25%
2010-12-31ยฃ10.85 M-10.7%
2009-12-31ยฃ12.15 M113.91%
2008-12-31ยฃ5.68 M35.94%
2007-12-31ยฃ4.18 M-8.08%
2006-12-31ยฃ4.54 M-40.68%
2005-12-31ยฃ7.66 M-18.79%
2004-12-31ยฃ9.44 M-24.77%
2003-12-31ยฃ12.55 M71.47%
2002-12-31ยฃ7.32 M156.8%
2001-12-31ยฃ2.85 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.27 B-90.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ79.08 M-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.42 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ48.61 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France